These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8379599)

  • 41. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
    Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
    Mehta P; Parker RI
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The genetics of thrombosis].
    Girolami A; Simioni P; Zanardi S; Coser E; Signora S
    Haematologica; 1991 Jun; 76 Suppl 3():249-60. PubMed ID: 1836447
    [No Abstract]   [Full Text] [Related]  

  • 44. Recurrent venous thromboembolism in patients with a partial deficiency of protein S.
    Comp PC; Esmon CT
    N Engl J Med; 1984 Dec; 311(24):1525-8. PubMed ID: 6239102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance to activated protein C: a common inherited cause of venous thrombosis.
    Gillespie DL; Carrington LR; Griffin JH; Alving BM
    Ann Vasc Surg; 1996 Mar; 10(2):174-7. PubMed ID: 8733870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein C deficiency--response to danazol and DDAVP.
    Gonzalez R; Alberca I; Sala N; Vicente V
    Thromb Haemost; 1985 Jun; 53(3):320-2. PubMed ID: 3840287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Familial antithrombin III deficiency as pathogenesis of deep venous thrombosis.
    Johansson L; Hedner U; Nilsson IM
    Acta Med Scand; 1978; 204(6):491-5. PubMed ID: 735880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anomalies of coagulation and fibrinolytic activity in patients with chronic pulmonary thromboembolism].
    Aiello E; Presbitero P; Stella S; Borchiellini A; Garis G; Bazzan M; Schinco P; Tamponi G
    G Ital Cardiol; 1993 Apr; 23(4):345-51. PubMed ID: 8319862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.
    Pabinger I; Brücker S; Kyrle PA; Schneider B; Korninger HC; Niessner H; Lechner K
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):547-53. PubMed ID: 1450321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein C deficiency. A cause of unusual or unexplained thrombosis.
    Tollefson DF; Friedman KD; Marlar RA; Bandyk DF; Towne JB
    Arch Surg; 1988 Jul; 123(7):881-4. PubMed ID: 3382355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism.
    Vikydal R; Korninger C; Kyrle PA; Niessner H; Pabinger I; Thaler E; Lechner K
    Thromb Haemost; 1985 Dec; 54(4):744-5. PubMed ID: 4089808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inherited heterozygous protein C deficiency and dysfunctional protein S with recurrent venous thrombotic diseases: a study of three generations of a Japanese family.
    Hashizume T; Tsushima N; Matsuo H; Ito A; Oozono K; Sakata T
    Intern Med; 1992 Oct; 31(10):1197-200. PubMed ID: 1286225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
    J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
    Levi M; Lensing AW; Büller HR; Prandoni P; Dooijewaard G; Cuppini S; ten Cate JW
    Thromb Haemost; 1991 Oct; 66(4):426-9. PubMed ID: 1796391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular genetics of familial venous thrombosis.
    Cooper DN; Tuddenham EG
    Br Med Bull; 1994 Oct; 50(4):833-50. PubMed ID: 7804734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haemostatic changes in patients with deep vein thrombosis.
    Trifiletti A; Scamardi R; Pizzoleo MA; Soraci S; Nevoso A; Bagnato L; Barbera N
    Panminerva Med; 1997 Mar; 39(1):21-3. PubMed ID: 9175416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.